INCYTE CORP (INCY)

NASDAQ:INCY, an undervalued stock with good fundamentals.

INCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying.

Incyte to Present at Upcoming Investor Conference

Incyte Corporation (INCY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Investors who lost money on Incyte Corporation should contact Levi & Korsinsky about an ongoing investigation - INCY

Incyte Corporation Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - INCY

3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer

Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma

Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Saia Moves Up In Market Cap Rank, Passing Incyte

Lineage Larger Than S&P 500 Component Incyte

Incyte Announces Updated Presentation Time for Upcoming Investor Conference

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting

Stock Market Rallies After Key Test; Nvidia, Target, Google, Bitcoin In Focus: Weekly Review

Many leaders flashed buy signals. Bitcoin raced toward $100,000.

Thursday Sector Laggards: Healthcare, Services

Notable Tuesday Option Activity: LW, RBLX, INCY

Tuesday Sector Laggards: Energy, Healthcare

S&P 500 Movers: INCY, SMCI

Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.

The company is discontinuing development of one drug and pausing enrollment in the study of another.

Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs

Incyte to Present at Upcoming Investor Conference

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Notable Wednesday Option Activity: INCY, PH, RCL

Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review

The major indexes declined, but haven't fallen apart.

Incyte Now the Most Expensive vs. Cardano This Year